Abstract:Juan Zhang, Juan Wu, Hongbin Zhang, Jie Li, Hezhou Li Department of Ultrasound, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China Correspondence: Hezhou Li, The Third Affiliated Hospital of Zhengzhou University, No. 7 Kangfuqian Street, Erqi District, Zhengzhou City, Henan Province, Email Purpose: To investigate whether fetal prenatal ultrasound, fetal growth rate, and pregnancy outcome statistically differ between women infected with novel coronavirus (COVID-19) in mid-pregnancy and an uninfected control group. Patients and Methods: A retrospective analysis of biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), femur length (FL), and z-scores for each among 46 pregnant women diagnosed with COVID-19 in mid-pregnancy between December 01, 2022 and June 31, 2023 was conducted. A control group included 92 pregnant women negative for COVID-19 during the same period and was also analyzed. To examine fetal growth, rate of increase in BPD, HC, AC, FL, and estimated fetal weight (EFW) between second and third trimester scans were analyzed. In addition, pregnancy outcome, maternal comorbidities, and neonatal prognosis were assessed. Results: The occurrence of gestational diabetes differed significantly between groups, but the fetal growth rate and EFW did not. Similarly, pregnancy outcomes and neonatal prognoses did not differ significantly between groups. Conclusion: Gestational diabetes was a complication that differed between patients with and without COVID-19 in this study. COVID-19 in pregnant women did not affect fetal development. Therefore, these preliminary data suggest that increased fetal monitoring is not necessary for women infected with COVID-19 during the second trimester, and these women should be reassured of the low risk of adverse fetal outcomes. Keywords: novel coronavirus, pregnant women, prenatal fetal growth, pregnancy outcome, ultrasound imaging During pregnancy, hormonal and physiological changes significantly affect the respiratory system. As a result, the risk of novel coronavirus (COVID-19) infection has been higher among pregnant women than among the general population. 1 However, approximately 92–95% of pregnant women diagnosed with COVID-19 have not experienced the severe spectrum of this disease. 1–3 Binding of the angiotensin-converting enzyme receptor 2 (ACE-2) is critical for the SARS-CoV-2 virus to gain access to host cells. ACE-2 is also expressed at higher levels in the uterus and placenta of pregnant women. 4,5 Consequently, there is an increased risk of virus entry to the posterior placenta. In addition, an increased incidence of decidual arterial lesions has been observed among pregnant women positive for SARS-CoV-2. 6,7 Thus, it is possible that SARS-CoV-2 may adversely affect placental function. Perinatal mother-to-child transmission of novel coronavirus (COVID-19) and impaired placental function are additional concerns. However, prenatal ultrasound studies conducted of fetuses in pregnant women infected with SARS-CoV-2 remain very limited. 8,9 In December 2022, China eased the strict COVID-related restrictions that had previously been imposed. One of the initial observations made regarding the cases of COVID-19 reported up to that point was the high proportion of pregnant women infected during their second trimester. Duan Li et al 10 studied the effects of COVID-19 infection in late pregnancy on pregnancy outcomes in China, but few reports describe the effects of COVID-19 in mid-gestation on fetuses. Thus, our objective was to examine and compare available data from women with and without a confirmed diagnosis of COVID-19 in mid-pregnancy and to identify any statistically significant differences in regard to prenatal ultrasound fetal growth rate or neonatal prognostic outcomes. Forty-six pregnant women confirmed to be positive for COVID-19 during their second trimester were admitted to the Third Affiliated Hospital of Zhengzhou University between December 01, 2022 and June 31, 2023 and retrospectively analyzed. All enrolled women had received perinatal care at our institution and were vaccinated. All of the women had their infection confirmed by positive real-time PCR analysis of nasopharyngeal swab specimens. The patients exhibited mild symptoms (cough, fever, loss of taste and smell, sore throat, diarrhea, etc), and were diagnosed with mild COVID-19 that did not require hospitalization. 11 All patients were free of underlying diseases and complications at the time of their second ultrasound examinations. For comparison, 92 pregnant women were identified from hospital records of 4150 women who delivered during the study period. This control group -Abstract Truncated-

Temporal Events Detector for Pregnancy Care (TED-PC): A rule-based algorithm to infer gestational age and delivery date from electronic health records of pregnant women with and without COVID-19

Development and validation of a machine learning algorithm for predicting the risk of postpartum depression among pregnant women

Detecting and Dating Early Non-live Pregnancy Outcomes: Generation of a Novel Pregnancy Algorithm From Norwegian Linked Health Registries

Using electronic medical records to understand the impact of SARS-CoV-2 lockdown measures on maternal and neonatal outcomes in Kampala, Uganda

A Prediction Model of Gestational Diabetes Mellitus Based on OGTT in Early Pregnancy: A Prospective Cohort Study

Associations of COVID-19 Pandemic with Clinical Manifestations among the Uninfected Pregnant Women in China: A Combined Cohort Study

Safe Delivery for Pregnancies Affected by COVID‐19

Electronic Health Record Driven Prediction for Gestational Diabetes Mellitus in Early Pregnancy

The effect of gestational age at the time of diagnosis on adverse pregnancy outcomes in women with COVID-19

Analysis of Fetal Growth and Pregnancy Outcome in Pregnant Women Infected with Novel Coronavirus in Mid-Pregnancy

Shadow of a Pandemic: Persistence of Prenatal SARS-CoV-2 Antibodies in Newborn Blood Spots

SARS-CoV-2 (COVID-19) infection in pregnant women: characterization of symptoms and syndromes predictive of disease and severity through real-time, remote participatory epidemiology

Risk for stillbirth among pregnant individuals with SARS-CoV-2 infection varied by gestational age

Estimated Date of Delivery with Electronic Medical Records by a Hybrid GBDT-GRU Model

Leveraging automated approaches to categorize birth defects from abstracted birth hospitalization data

Maternal and neonatal outcomes and clinical laboratory testing of pregnant women with COVID-19 during the BA.5.2/BF.7 surge

Multilevel Determinants of Racial/ethnic Disparities in Severe Maternal Morbidity and Mortality in the Context of the COVID-19 Pandemic in the USA: Protocol for a Concurrent Triangulation, Mixed-Methods Study

Development and validation of claims-based algorithms for estimating gestational age of spontaneous abortion and termination

A Retrospective Case Series Analysis of Pregnancy and COVID-19 Based on a Global Postmarketing COVID-19 Surveillance Program

Development and Validation of Multi-Stage Prediction Models for Pre-eclampsia: A Retrospective Cohort Study on Chinese Women

COVID-19 patient cohort identification during the SARS-CoV-2 outbreak through a tertiary hospital Electronic Health Record alert system (Preprint)